UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

The Nootropic Drug Α-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects in Human Hippocampal Cells

International journal of molecular sciences, 2020-01, Vol.21 (3), p.941

2020

Volltextzugriff (PDF)

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors

PloS one, 2020-02, Vol.15 (2), p.e0228509-e0228509

2020

Volltextzugriff (PDF)

Effect of Sodium Hypochlorite 0.05% on MMP-9 Extracellular Release in Chronic Wounds

Journal of clinical medicine, 2023-04, Vol.12 (9), p.3189

2023

Volltextzugriff (PDF)

Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations

Clinical and translational science, 2022-06, Vol.15 (6), p.1417-1429

2022

Volltextzugriff (PDF)

Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis

PloS one, 2012-07, Vol.7 (7), p.e40576

2012

Volltextzugriff (PDF)

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo

Frontiers in pharmacology, 2020-04, Vol.11, p.374-374

2020

Volltextzugriff (PDF)

Discovery and Pharmacological Profile of New 1H‑Indazole-3-carboxamide and 2H‑Pyrrolo[3,4‑c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands

Journal of medicinal chemistry, 2012-11, Vol.55 (22), p.9446-9466

2012

Volltextzugriff (PDF)

Effects of AF3442 [ N-(9-ethyl-9 H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro

Biochemical pharmacology, 2010-04, Vol.79 (7), p.974-981

2010

Volltextzugriff (PDF)

Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils

Journal of leukocyte biology, 2007-08, Vol.82 (2), p.320-326

2007

Volltextzugriff (PDF)

α‐Glyceryl‐phosphoryl‐ethanolamine protects human hippocampal neurons from ageing‐induced cellular alterations

The European journal of neuroscience, 2022-09, Vol.56 (5), p.4514-4528

2022

Volltextzugriff (PDF)

The Nootropic Drug A-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects in Human Hippocampal Cells

International journal of molecular sciences, 2020-02, Vol.21 (3), p.941

2020

Volltextzugriff (PDF)

Structure-Based Discovery of 1H‑Indazole-3-carboxamides as a Novel Structural Class of Human GSK‑3 Inhibitors

Journal of chemical information and modeling, 2015-12, Vol.55 (12), p.2540-2551

2015

Volltextzugriff (PDF)

Benzydamine inhibits neuronal excitability induced by inflammatory mediators to relieve pain

Biophysical journal, 2022-02, Vol.121 (3), p.504a-505a

2022

Volltextzugriff (PDF)

Benzydamine plays a role in limiting inflammatory pain induced by neuronal sensitization

Molecular pain, 2023-01, Vol.19

2023

Volltextzugriff (PDF)

New insights on the arylpiperazinylalkyl pyridazinone ET1 as potent antinociceptive and anti-inflammatory agent

European journal of pharmacology, 2020-12, Vol.888, p.173572-173572, Article 173572

2020

Volltextzugriff (PDF)

Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models

Clinical & experimental metastasis, 2012-08, Vol.29 (6), p.585-601

2012

Volltextzugriff (PDF)

Structure-Based Discovery of 1 H -Indazole-3-carboxamides as a Novel Structural Class of Human GSK-3 Inhibitors

Journal of chemical information and modeling, 2015-12, Vol.55 (12), p.2540-2551

2015

Volltextzugriff (PDF)

Virtual Screening Approach and Investigation of Structure–Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens

Journal of medicinal chemistry, 2019-08, Vol.62 (16), p.7445-7472

2019

Volltextzugriff (PDF)

Hit Optimization of 5‑Substituted‑N‑(piperidin-4-ylmethyl)‑1H‑indazole-3-carboxamides: Potent Glycogen Synthase Kinase‑3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

Journal of medicinal chemistry, 2015-11, Vol.58 (22), p.8920-8937

2015

Volltextzugriff (PDF)

Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants

Experimental dermatology, 2023-07, Vol.32 (7), p.999-1006

2023

Volltextzugriff (PDF)

A specific combination of nutraceutical Ingredients exerts cytoprotective effects in human cholinergic neurons

PharmaNutrition, 2022-12, Vol.22, p.100317, Article 100317

2022

Volltextzugriff (PDF)

Design and Validation of Novel Potential Antiperspirant Peptides Blocking M3-Gαq Sweat Signaling Cascade

International journal of peptide research and therapeutics, 2024-07, Vol.30 (4), p.47, Article 47

2024

Volltextzugriff (PDF)

The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling

Pharmacological research, 2012-12, Vol.66 (6), p.526-535

2012

Volltextzugriff (PDF)

Optimization of Indazole-Based GSK‑3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model

ACS medicinal chemistry letters, 2020-05, Vol.11 (5), p.825-831

2020

Volltextzugriff (PDF)

Targeting Serotonin 2A and Adrenergic α1 Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐b]indazol‐1(2H)‐one Derivatives

ChemMedChem, 2018-08, Vol.13 (15), p.1597-1607

2018

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Nootropic Drug Α-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects in Human Hippocampal Cells

Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors

Effect of Sodium Hypochlorite 0.05% on MMP-9 Extracellular Release in Chronic Wounds

Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations

Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis

Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo

Discovery and Pharmacological Profile of New 1H‑Indazole-3-carboxamide and 2H‑Pyrrolo[3,4‑c]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands

Effects of AF3442 [ N-(9-ethyl-9 H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro

Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils

α‐Glyceryl‐phosphoryl‐ethanolamine protects human hippocampal neurons from ageing‐induced cellular alterations

The Nootropic Drug A-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects in Human Hippocampal Cells

Structure-Based Discovery of 1H‑Indazole-3-carboxamides as a Novel Structural Class of Human GSK‑3 Inhibitors

Benzydamine inhibits neuronal excitability induced by inflammatory mediators to relieve pain

Benzydamine plays a role in limiting inflammatory pain induced by neuronal sensitization

New insights on the arylpiperazinylalkyl pyridazinone ET1 as potent antinociceptive and anti-inflammatory agent

Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models

Structure-Based Discovery of 1 H -Indazole-3-carboxamides as a Novel Structural Class of Human GSK-3 Inhibitors

Virtual Screening Approach and Investigation of Structure–Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens

Hit Optimization of 5‑Substituted‑N‑(piperidin-4-ylmethyl)‑1H‑indazole-3-carboxamides: Potent Glycogen Synthase Kinase‑3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants

A specific combination of nutraceutical Ingredients exerts cytoprotective effects in human cholinergic neurons

Design and Validation of Novel Potential Antiperspirant Peptides Blocking M3-Gαq Sweat Signaling Cascade

The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling

Optimization of Indazole-Based GSK‑3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model

Targeting Serotonin 2A and Adrenergic α1 Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐b]indazol‐1(2H)‐one Derivatives

Suchergebnisse filtern